Accurate zone (%) | Danger zone (%) | Magnification zone (%) | |
---|---|---|---|
Sex of child | |||
Male (n=110) | 55.0±2.2 | 26.6±2.3 | 18.4±2.1 |
Female (n=82) | 55.0±2.6 | 28.3±2.7 | 16.8±2.4 |
p Value | 0.991 | 0.638 | 0.609 |
Ethnicity | |||
Puerto Rican (n=100) | 56.3±2.3 | 28.4±2.4 | 15.2±2.2 |
African-American (n=54) | 57.6±3.2 | 23.6±3.3 | 18.8±3.0 |
Afro-Caribbean (n=38) | 47.7±3.8 | 29.6±4.0 | 22.6±3.6 |
p Value | 0.101 | 0.409 | 0.189 |
Poverty threshold | |||
Below (n=90) | 55.4±2.5 | 26.5±2.6 | 18.1±2.4 |
Above (n=92) | 54.5±2.4 | 27.1±2.5 | 18.3±2.3 |
p Value | 0.806 | 0.868 | 0.939 |
Parent nativity | |||
US-born parent (n=120) | 57.6±2.1 | 26.4±2.2 | 16.0±2.0 |
Foreign-born parent (n=69) | 50.2±2.8 | 28.4±2.9 | 21.4±2.6 |
p Value | 0.035 | 0.592 | 0.103 |
Asthma severity | |||
Intermittent/mild persistent (n=21) | 50.3±5.1 | 24.6±5.4 | 25.0±4.8* |
Moderate persistent (n=105) | 53.8±2.3 | 26.5±2.4 | 19.7±2.1 |
Severe persistent (n=52) | 56.6±3.2 | 32.2±3.4 | 11.1±3.0* |
p Value | 0.556 | 0.315 | 0.020 |
ICS medication use | |||
Yes (n=115) | 56.6±2.2 | 26.2±2.3 | 17.2±2.1 |
No (n=77) | 52.6±2.7 | 28.9±2.8 | 18.5±2.5 |
p Value | 0.249 | 0.454 | 0.693 |
Values represent mean±SE of the mean.
*Intermittent/mild persistent versus severe persistent, p=0.04.
ICS, inhaled corticosteroids.